Please login to the form below

Not currently logged in
Email:
Password:

Hill+Knowlton Strategies creates EMEA division

Will be led by European president Lars Erik Grønntun
HK-Strategies_Gronntun-Lars-Erik

Lars Erik Grønntun

Global communications agency Hill+Knowlton Strategies has restructured, bringing its Europe, Middle East and Africa operations together.

Current present of H+K Europe and chairman of H + K Norway Lars Erik Grønntun will be chairman and CEO of the new EMEA region, effective immediately. Grønntun will report to global chairman and CEO Jack Martin and will remain a member of H+K Strategies' global leadership group. 

“By connecting and unifying the vast EMEA region under Lars Erik we will take advantage of the increased internationalisation of trade and business by becoming more integrated, more competitive, and with much better utilisation of our expertise from around the network,” said Martin.

Sconaid McGeachin remains president for H+K operations in Africa, Middle East & Turkey, reporting to Grønntun.

Grønntun said he was honoured to take on his new role and underlined the importance of the restructure to the company.

“I believe that our understanding of local markets together with our international mind-set and reach is a powerful combination for clients. As such, leading the charge in EMEA is deeply inspiring,” he added.

H+K has also appointed Richard Millar global chair, creative strategy, to spearhead a global creative initiative. He remains CEO of H+K's UK operation and continues to report to Jack Martin.

Hill+Knowlton Strategies provides communications services to local, multinational and global clients. Headquartered in New York, with 89 offices in 52 countries, the agency is part of comms group WPP.

Article by
Tara Craig

23rd May 2014

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Six Degrees Medical Consulting

For over a decade, our medical communication services have helped pharmaceutical companies optimize their brand, disease and corporate objectives. Building...

Latest intelligence

Tapping the potential of rare diseases: A journey into uncharted territory
...
The 2019 WHO essential medicine list: Narrowing the access gap to innovative cancer treatments
The essential medicine list (EML) contains treatments considered to be the most effective and safe in targeting global health concerns. On 9 July 2019, the World Health Organization (WHO) published...
NICE
Evolution or revolution: the latest review of NICE methods
By Leela Barham...

Infographics